南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

α-阿萨龙通过恢复小胶质细胞的吞噬-溶酶体平衡,经由SPP1-mTOR-TFEB轴发挥作用,减轻APP/PS1小鼠的突触损伤。

α-Asarone attenuates synaptic loss in APP/PS1 mice by restoring microglial phagocytic-lysosomal balance via the SPP1-mTOR-TFEB axis

Haitao Jiang, Longmin Fan, Jiancong He, Zheyu Zhang

Journal:PHYTOMEDICINE

IF:11.3

DOI:10.1016/j.phymed.2026.158720

PMID:

Published:2026-08-13

research field:肿瘤学细胞生物学遗传学与基因组学

Abstract

SPP1 drives microglial phagocytic-lysosomal imbalance in AD. • The SPP1-mTOR-TFEB axis mediates microglia-associated synaptic injury. • α-Asarone suppresses SPP1-associated mTOR hyperactivation in microglia. • α-Asarone restores lysosomal function and reduces synaptic engulfment. • α-Asarone improves behavioral deficits in APP/PS1 mice. Background Synaptic loss in Alzheimer disease (AD) is closely linked to aberrant microglial phagocytosis. Complement-dependent synaptic pruning and microglial lysosomal dysfunction drive this process, yet effective pharmacological strategies targeting this axis are lacking. α-Asarone (ASA) is neuroprotective, but its effects on SPP1-centered microglial synaptic pathology remain unclear. Purpose To determine whether ASA protects against AD-related synaptic injury by modulating SPP1-associated microglial phagocytic-lysosomal dysfunction and define the underlying mechanism. Study Design An integrated in vivo and in vitro pharmacological study was performed using APP/PS1 mice and BV2 microglia. Methods Six-month-old APP/PS1 mice were treated with ASA for 100 days and evaluated behaviorally. ASA effects on microglial complement activation, complement-tagged synapses, lysosomal dysfunction, and hippocampal synaptic injury were assessed by transcriptomic analysis, qPCR, western blotting, immunofluorescence, Golgi staining, and transmission electron microscopy. In Aβ-stimulated BV2 cells, the role of SPP1 in phagocytic–lysosomal dysfunction was evaluated using SPP1 knockdown and recombinant SPP1, together with assays of lysosomal acidification, DQ-BSA degradation, and TFEB subcellular localization. Potential ASA–SPP1 engagement was further assessed by molecular docking, molecular dynamics simulation, and cellular thermal shift assay. Results ASA improved behavioral performance and preserved hippocampal synaptic integrity in APP/PS1 mice. It reduced complement-associated microglial activation, CR3 signal, and complement deposition on PSD95-

本文使用的Yeasen产品

相关产品
购物车
客服
转染试用